For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection ...

Zoliflodacin is the first of a new class of antibiotics, called spiropyrimidinetriones, that have activity against Neisseria ...

Aug. 7 (UPI) --A new test for gonorrhea can determine whether those infected will respond successfully to the inexpensive oral antibiotic ciprofloxacin, according to a study published Friday by ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Gonorrhea is the second most common notifiable disease ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections ...

Background and Goal: Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce transmission. Adherence to the Centers for Disease ...

The WHO has labeled drug-resistant gonorrhea a serious and urgent public health threat. If left untreated, gonorrhea ...

The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NEXSTAR) – Medical researchers in Europe ...

For the first time in nearly 40 years, patients with uncomplicated urogenital gonorrhea have new oral treatment options.